SecBot SecBot
8-K ·Filed Mar 11, 2026

BTAI

BioXcel Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001104659-26-026409
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

Wait for the actual filing to be available to assess the material agreement's impact. Monitor for press releases or investor communications from BioXcel Therapeutics that may disclose further details.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d
BTAI ▼ -28.71% at T+60d
NEUTRAL call -28.71% · α vs SPY -39.41% · entry $1.55 → $1.11
Entry = T+0 close
Mar 11, 2026
via day close
T+1d
-3.87%
call -3.87% · α -3.27%
$1.49
settled 8mo ago
T+5d
+3.23%
call +3.23% · α +4.20%
$1.60
settled 7mo ago
T+20d
-31.61%
call -31.61% · α -33.59%
$1.06
settled 7mo ago
T+60d
-28.71%
call -28.71% · α -39.41%
$1.11
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The filing is an 8-K with Items 1.01 (Entry into Material Agreement) and 9.01 (Financial Statements and Exhibits), suggesting a potential new agreement or contract was announced, but no details are accessible to assess its nature or impact.

Key Facts

  • Filing type is 8-K, indicating a material event.
  • Items reported: 1.01 (Entry into Material Agreement) and 9.01 (Financial Statements and Exhibits).
  • No document content available to determine the agreement's nature, parties involved, or financial terms.
  • Market cap of BTAI is $34M as per snapshot.

Financial Impact

Unknown — no financial details available from the filing.

Risk Factors

  • Inability to assess potential dilution, cash impact, or strategic implications due to missing data.
  • Risk of delayed reaction if the agreement is significant and already priced in by the market.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

Report based on filing metadata.

14 reports for BTAI
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 10 of 10 best @ T+20▲ +95.39%Aug 11, 2026
Filters
Rows
Reports for BTAI — sortable, filterable
TypeNow
Sep 1, 2026
7w ago
8-K
BEARISH ★ 9/10
$0.1370awaiting T+60——
Aug 28, 2026
8w ago
Press Release
BEARISH ★ 9/10
$0.1814awaiting T+60——
Aug 25, 2026
8w ago
8-K
BEARISH ★ 8/10
$0.7422awaiting T+60——
Aug 11, 2026
10w ago
8-K
BEARISH ★ 7/10
$0.9320awaiting T+60——
Aug 3, 2026
12w ago
8-K
BEARISH ★ 7/10
$0.8480awaiting T+60——
Jul 6, 2026
16w ago
8-K
BEARISH ★ 7/10
$1.10awaiting T+60——
May 22, 2026
22w ago
Insider Cluster
BEARISH ★ 5/10
$1.22 $0.8274▲ +32.18%▲ +34.91%—
May 20, 2026
22w ago
144
NEUTRAL ★ 2/10
$1.14 $0.8900▼ −21.93%▼ −26.23%—
May 15, 2026
23w ago
8-K
NEUTRAL ★ 6/10
$1.14 $0.9319▼ −18.25%▼ −22.77%—
May 15, 2026
23w ago
Press Release
BEARISH ★ 6/10
$1.14 $0.9319▲ +18.25%▲ +22.77%—
Showing 10 of 14

US Market Status

Market Closed — Opens Tue (15h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 11, 2026